Each month, GHEA aggregates the latest news and research related to place-based cancer control and geographic health disparities. Below you will find the latest posts, updated regularly throughout the month.
(Last updated: November 22, 2021)
General Cancer Control News and Research
- New data has been added to the CDC’s U.S. Cancer Statistics Data Visualization tool. This data includes cancer screening rates, HPV vaccination coverage estimates and cancer data on stage at diagnosis and survival by stage.
- Researchers are testing a vaccine that aims to prevent triple-negative breast cancer in human trials in the U.S.
- A study finds that unemployment is adversely associated with recommended cancer screenings. In the study sample, the association was caused by lack of health insurance.
- Researchers find that artificial intelligence can accurately detect and diagnose colorectal cancer from tissue scans, as well as or better than, pathologists.
- A study finds that the cumulative annual revenue from cancer drug sales increased by 70 percent among the world’s largest pharmaceutical companies between 2010-2019.
- The National Cancer Institute released a new analysis on patient economic burden of cancer care in the U.S. The analysis found that in 2019, the national patient economic burden associated with cancer care was $21.09 billion, made up of patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.
- Researchers have identified a molecule in certain kinds of breast cancers that prevent immune cells from entering and killing tumors.
- Research shows that over the past 50 years, we have made extreme strides in defeating cancer diagnoses, with the help of funding towards early detection and improved treatment plans.
- A new study’s findings show that women with breast cancer are more likely to begin developing an abnormal heart rhythm known as atrial fibrillation within their first year of diagnoses.
- The FDA has granted new “Breakthrough Device Designation” blood tests that will be able to detect breast cancer in its early stages.
